Integre Asset Management’s Medtronic MDT Stock Holding History

Integre Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-965	Closed	-$78K	–	130
2017 Q4	$78K	Buy	+965	New	+$77.3K	0.05%	169

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Integre Asset Management's MDT Position: Q1 2018 in Review

Integre Asset Management sold out of Medtronic (MDT) in Q1 2018, closing a stake of 965 shares — an estimated $78K sold.

Integre Asset Management first reported a position in MDT in Q4 2017 and held it in 1 quarter. The position peaked at $78K in Q4 2017. 1,381 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

Integre Asset Management reported no remaining Medtronic position as of Q1 2018 after selling out during the quarter.
Integre Asset Management sold 965 Medtronic shares in Q1 2018, an estimated $78K.
Integre Asset Management first reported a position in Medtronic in Q4 2017 and held it in 1 quarter.
Integre Asset Management's Medtronic position peaked at $78K in Q4 2017.
1,381 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on Integre Asset Management's 13F filing for Q1 2018, filed 16 May 2018.